GNLX
Price
$2.31
Change
-$0.09 (-3.75%)
Updated
Dec 18, 04:59 PM (EDT)
PLRX
Price
$14.01
Change
-$0.36 (-2.51%)
Updated
Dec 18, 04:59 PM (EDT)
76 days until earnings call
Ad is loading...

GNLX vs PLRX

Header iconGNLX vs PLRX Comparison
Open Charts GNLX vs PLRXBanner chart's image
Genelux
Price$2.31
Change-$0.09 (-3.75%)
Volume$1.05K
CapitalizationN/A
Pliant Therapeutics
Price$14.01
Change-$0.36 (-2.51%)
Volume$26.57K
CapitalizationN/A
GNLX vs PLRX Comparison Chart
Loading...
GNLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GNLX vs. PLRX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNLX is a Hold and PLRX is a StrongBuy.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (GNLX: $2.40 vs. PLRX: $14.37)
Brand notoriety: GNLX and PLRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GNLX: 41% vs. PLRX: 79%
Market capitalization -- GNLX: $82.89M vs. PLRX: $874.47M
GNLX [@Biotechnology] is valued at $82.89M. PLRX’s [@Biotechnology] market capitalization is $874.47M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNLX’s FA Score shows that 0 FA rating(s) are green whilePLRX’s FA Score has 0 green FA rating(s).

  • GNLX’s FA Score: 0 green, 5 red.
  • PLRX’s FA Score: 0 green, 5 red.
According to our system of comparison, PLRX is a better buy in the long-term than GNLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GNLX’s TA Score shows that 3 TA indicator(s) are bullish while PLRX’s TA Score has 6 bullish TA indicator(s).

  • GNLX’s TA Score: 3 bullish, 6 bearish.
  • PLRX’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, PLRX is a better buy in the short-term than GNLX.

Price Growth

GNLX (@Biotechnology) experienced а -11.76% price change this week, while PLRX (@Biotechnology) price change was -1.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.

Reported Earning Dates

GNLX is expected to report earnings on Nov 14, 2024.

PLRX is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PLRX($874M) has a higher market cap than GNLX($82.9M). PLRX YTD gains are higher at: -20.652 vs. GNLX (-82.869). GNLX has higher annual earnings (EBITDA): -26.78M vs. PLRX (-197.04M). PLRX has more cash in the bank: 405M vs. GNLX (34.1M). GNLX has less debt than PLRX: GNLX (2.04M) vs PLRX (60.2M). GNLX has higher revenues than PLRX: GNLX (8K) vs PLRX (0).
GNLXPLRXGNLX / PLRX
Capitalization82.9M874M9%
EBITDA-26.78M-197.04M14%
Gain YTD-82.869-20.652401%
P/E RatioN/AN/A-
Revenue8K0-
Total Cash34.1M405M8%
Total Debt2.04M60.2M3%
TECHNICAL ANALYSIS
Technical Analysis
GNLXPLRX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
77%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
70%
View a ticker or compare two or three
Ad is loading...
GNLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SUM50.770.02
+0.04%
Summit Materials
LLY778.62-0.38
-0.05%
Eli Lilly & Co
XAIR0.46-0.01
-1.13%
Beyond Air
ANDE42.93-0.84
-1.92%
Andersons
HAFC25.44-1.03
-3.89%
Hanmi Financial Corp

GNLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GNLX has been loosely correlated with VSTM. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if GNLX jumps, then VSTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNLX
1D Price
Change %
GNLX100%
+1.69%
VSTM - GNLX
48%
Loosely correlated
-1.71%
SNSE - GNLX
32%
Poorly correlated
+11.97%
FHTX - GNLX
29%
Poorly correlated
N/A
PLRX - GNLX
28%
Poorly correlated
+4.74%
ZLDAF - GNLX
26%
Poorly correlated
N/A
More

PLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with NTLA. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLRX
1D Price
Change %
PLRX100%
+4.74%
NTLA - PLRX
53%
Loosely correlated
-1.87%
BEAM - PLRX
51%
Loosely correlated
-1.21%
RCKT - PLRX
51%
Loosely correlated
+1.36%
CRSP - PLRX
50%
Loosely correlated
+0.88%
PRME - PLRX
50%
Loosely correlated
-3.00%
More